2026. Bevacizumab in Advanced High Grade Serous Ovarian Cancer: The Impact of BRCA Mutation Status. Journal of Cancer Research Updates. 15, 1 (Jan. 2026), 1–10. DOI:https://doi.org/10.30683/1929-2279.2026.15.01.